BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 241 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $177 | -46.7% | 25 | -50.0% | 0.00% | – |
| Q2 2023 | $332 | +104.9% | 50 | +92.3% | 0.00% | – |
| Q1 2023 | $162 | +362.9% | 26 | -99.5% | 0.00% | -100.0% |
| Q4 2022 | $35 | -99.9% | 5,543 | -3.6% | 0.00% | 0.0% |
| Q3 2022 | $36,000 | 0.0% | 5,751 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $36,000 | -2.7% | 5,751 | -1.3% | 0.00% | – |
| Q1 2022 | $37,000 | +3600.0% | 5,829 | +7373.1% | 0.00% | – |
| Q4 2021 | $1,000 | -85.7% | 78 | -85.5% | 0.00% | – |
| Q3 2021 | $7,000 | -95.0% | 538 | -93.9% | 0.00% | -100.0% |
| Q2 2021 | $140,000 | +122.2% | 8,822 | +44.6% | 0.00% | +200.0% |
| Q1 2021 | $63,000 | +14.5% | 6,099 | -16.4% | 0.00% | -50.0% |
| Q4 2020 | $55,000 | +685.7% | 7,295 | +231.6% | 0.00% | – |
| Q3 2020 | $7,000 | – | 2,200 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q3 2017 | $5,000 | -16.7% | 1,000 | 0.0% | 0.00% | – |
| Q2 2017 | $6,000 | -25.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2017 | $8,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
| Q4 2016 | $6,000 | +50.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2016 | $4,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | -70.0% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $10,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 864,916 | $13,674,000 | 13.71% |
| Sarissa Capital Management LP | 4,261,000 | $67,366,000 | 5.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,920,733 | $30,367,000 | 4.18% |
| HealthCor Management, L.P. | 3,248,100 | $51,352,000 | 2.05% |
| Parkman Healthcare Partners LLC | 351,961 | $5,565,000 | 1.22% |
| Bain Capital Public Equity Management II, LLC | 1,560,730 | $24,675,000 | 1.06% |
| Baker Brothers Advisors | 12,710,818 | $200,958,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,835,000 | $44,821,000 | 0.80% |
| Biondo Investment Advisors, LLC | 265,840 | $4,203,000 | 0.72% |
| EAM Global Investors LLC | 157,065 | $2,483,000 | 0.69% |